Latest debt-to-equity ratio
Bolt Biotherapeutics Debt-to-equity ratio
Direct answer
Bolt Biotherapeutics's debt-to-equity ratio is 171.08%.
The verified market snapshot reports 171.08%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 171.08%
Explore related company data
View Bolt Biotherapeutics's market capitalizationView Bolt Biotherapeutics's price-to-book ratioView Bolt Biotherapeutics's return on equityView Bolt Biotherapeutics's dividend yieldView Bolt Biotherapeutics's 52-week price rangeView Bolt Biotherapeutics's revenue growthView Bolt Biotherapeutics's profit marginView all Bolt Biotherapeutics key metricsReturn to Bolt Biotherapeutics profile